1 line
3.2 KiB
JSON
1 line
3.2 KiB
JSON
{"Acute kidney injury": 3.5851486976304927, "Acute respiratory distress syndrome": 4.094149838556442, "Anaemia": 3.913661570091872, "Ascites": 2.2309839200119974, "Atypical haemolytic uraemic syndrome": 125.2637112436148, "Blood calcium increased": 13.515864915300591, "Blood disorder": 13.584562119208272, "Bone marrow disorder": 30.565504671558973, "Brain fog": 2.363486417080244, "COVID-19 pneumonia": 6.440536399999098, "Cardiac failure": 7.918452717187726, "Cardiac failure acute": 7.419773910700125, "Cardiogenic shock": 3.7867386506532057, "Cardiotoxicity": 10.557828043198452, "Cellulitis": 2.3803757695422783, "Cerebral toxoplasmosis": 346.2864830931254, "Cytokine release syndrome": 6.1128388062867485, "Cytopenia": 23.23546901622097, "Deep vein thrombosis": 2.203997307424602, "Disease progression": 4.807039795800443, "Ejection fraction decreased": 4.877940809146613, "Febrile neutropenia": 6.066636984106319, "Fibrosis": 19.57324064135173, "Gastrointestinal disorder": 2.1591648407306248, "Haematotoxicity": 6.9023314875150845, "Haemolytic anaemia": 5.752385116305821, "Haemolytic uraemic syndrome": 21.99312525787101, "Hepatic steatosis": 3.2251822089842617, "Hypogammaglobulinaemia": 19.8432950123894, "Infection": 2.56980588763494, "Infusion related reaction": 4.640315916973252, "Intentional product use issue": 15.960984668492689, "JC virus infection": 176.82930722414977, "Leukopenia": 2.4371426426508718, "Light chain disease": 477.96203698013977, "Lymphopenia": 6.261356570111651, "Microangiopathic haemolytic anaemia": 123.6405543500362, "Mucosal inflammation": 3.486386134200535, "Multiple organ dysfunction syndrome": 4.015118981506092, "Myelodysplastic syndrome": 5.278630910491181, "Myelosuppression": 5.191808359462111, "Neuropathy peripheral": 6.836430803330305, "Neutropenia": 4.184938197693499, "Neutrophil count decreased": 2.031502141344024, "Off label use": 6.006501615110173, "Osteolysis": 78.96488043202325, "Pancytopenia": 5.326353159020804, "Plasma cell leukaemia": 126.22919797924509, "Plasma cell myeloma": 250.0388566141349, "Plasma cell myeloma recurrent": 310.2636980620203, "Plasma cell myeloma refractory": 656.0675874662888, "Plasmacytoma": 185.71442302218583, "Platelet count decreased": 3.127214481702075, "Pleural effusion": 3.8327330681176544, "Pneumonia": 3.280341045148388, "Pneumonia fungal": 15.851280353513491, "Polyneuropathy": 4.586160675794254, "Posterior reversible encephalopathy syndrome": 5.375223660887612, "Progressive multifocal leukoencephalopathy": 77.84407383075437, "Pulmonary arterial hypertension": 5.583655652710875, "Pulmonary hypertension": 7.909881017508173, "Pulmonary oedema": 3.373550944249354, "Pulseless electrical activity": 12.876809938230435, "Renal failure": 2.4570197317343787, "Respiratory failure": 2.9515665991546904, "Respiratory tract infection": 4.526327821667148, "Sepsis": 4.331575274866037, "Septic shock": 2.012187393393294, "Therapeutic product effect incomplete": 3.1316525731392773, "Therapy non-responder": 15.588863225785818, "Therapy partial responder": 65.95567922975067, "Thrombocytopenia": 6.238551865863011, "Thrombotic microangiopathy": 86.18335270529403, "Tumour lysis syndrome": 36.26349571983143, "Upper respiratory tract infection": 2.028249328905961} |